LEYDIS PEREIRA: Open Payments
NPI 1316695935 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,890 in 140 payments from 39 companies in 2025. Trend: 2023 $2,265 · 2024 $2,414 · 2025 $2,890
Food & beverage: $2,890
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 30 | $473 |
| Merck Sharp & Dohme LLC | 17 | $446 |
| Genentech USA, Inc. | 12 | $190 |
| GENZYME CORPORATION | 7 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $129 |
| AstraZeneca Pharmaceuticals LP | 5 | $112 |
| Daiichi Sankyo Inc. | 4 | $101 |
| ARRAY BIOPHARMA INC | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Eisai Inc. | 4 | $73 |
Products named: KEYTRUDA, TIVDAK, ELREXFIO, REBLOZYL, IBRANCE, SARCLISA, WELIREG, Itovebi.
Industry payments across FL — which companies pay providers there.
